Status:
COMPLETED
Efficacy Study of the Combination Mometasone + Salicylic Acid in Patients With Psoriasis
Lead Sponsor:
Azidus Brasil
Conditions:
Psoriasis
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
To evaluate the efficacy of the combination of mometasone furoate 0.1% and Salicylic Acid 5% in patients of both sexes who presented clinical symptoms of psoriasis of mild to moderate.
Detailed Description
Phase III clinical trial, systematic sampling, open-label study that evaluated the efficacy of the combination of mometasone furoate 0.1% and 5% salicylic acid in 71 patients with lesions of mild to m...
Eligibility Criteria
Inclusion
- Adults of both sexes, regardless of color or social class;
- Age 18 or older, with good mental health;
- Psoriasis patients with mild to moderate;
- Patients who agreed to participate and signed the
- Clarified (appendix);
- Patients who agreed to return for follow-up visits.
Exclusion
- Patients who were making use of biologics, corticosteroids or nonsteroidal anti-inflammatory and non-steroid, or who made use of these topical medications until 15 days before inclusion or 30 days before inclusion when the administration was orally;
- Patients who were exposed to the sun 15 days before the study began or during the course of the same;
- Patients who were making use of acetaminophen;
- Patients who did not agree to the terms described in the IC informed consent, - Patients who also had psoriatic plaques of skin disorders caused by fungi or bacteria and they were making use of antibiotic or antifungal;
- Lions and other types of skin damage that was not psoriasis;
- Pregnant and nursing women;
- Patients using oral anticoagulants.
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2007
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT01229085
Start Date
September 1 2006
End Date
October 1 2007
Last Update
October 27 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
LAL Clinica Pesquisa e Desenvolvimento Ltda.
Valinhos, São Paulo, Brazil, 13270000